Weight Management in T2D — SCE Endocrinology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Recommend structured weight loss; consider GLP-1 RA and bariatric surgery if indicated
Weight reduction via lifestyle, anti-obesity pharmacotherapy (GLP-1 RA), and metabolic surgery in eligible patients improves glycaemia and CV risk. Insulin-induced weight gain is not a strategy; avoiding exercise is harmful; HCG is not recommended.
Reference: ADA Standards of Care (2025): Obesity and Weight Management for the Prevention and Treatment of T2D